These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 16892199)

  • 1. Modifications of aminoglycoside antibiotics targeting RNA.
    Zhou J; Wang G; Zhang LH; Ye XS
    Med Res Rev; 2007 May; 27(3):279-316. PubMed ID: 16892199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.
    Hainrichson M; Nudelman I; Baasov T
    Org Biomol Chem; 2008 Jan; 6(2):227-39. PubMed ID: 18174989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures.
    Vicens Q; Westhof E
    Biopolymers; 2003 Sep; 70(1):42-57. PubMed ID: 12925992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamics of aminoglycoside-rRNA recognition.
    Pilch DS; Kaul M; Barbieri CM; Kerrigan JE
    Biopolymers; 2003 Sep; 70(1):58-79. PubMed ID: 12925993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel paromamine derivatives exploring shallow-groove recognition of ribosomal-decoding-site RNA.
    Simonsen KB; Ayida BK; Vourloumis D; Takahashi M; Winters GC; Barluenga S; Qamar S; Shandrick S; Zhao Q; Hermann T
    Chembiochem; 2002 Dec; 3(12):1223-8. PubMed ID: 12465030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design, synthesis and A-site rRNA co-crystal complexes of novel amphiphilic aminoglycoside antibiotics with new binding modes: a synergistic hydrophobic effect against resistant bacteria.
    Hanessian S; Pachamuthu K; Szychowski J; Giguère A; Swayze EE; Migawa MT; François B; Kondo J; Westhof E
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7097-101. PubMed ID: 20970332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel acyclic deoxystreptamine mimetics targeting the ribosomal decoding site.
    Vourloumis D; Winters GC; Takahashi M; Simonsen KB; Ayida BK; Shandrick S; Zhao Q; Hermann T
    Chembiochem; 2003 Sep; 4(9):879-85. PubMed ID: 12964163
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
    Yan RB; Yuan M; Wu Y; You X; Ye XS
    Bioorg Med Chem; 2011 Jan; 19(1):30-40. PubMed ID: 21177112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of distribution of amino groups modulates the structure and dynamics of natural aminoglycosides: implications for RNA recognition.
    Corzana F; Cuesta I; Freire F; Revuelta J; Torrado M; Bastida A; Jiménez-Barbero J; Asensio JL
    J Am Chem Soc; 2007 Mar; 129(10):2849-65. PubMed ID: 17298063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
    Blount KF; Zhao F; Hermann T; Tor Y
    J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics.
    Busscher GF; Rutjes FP; van Delft FL
    Chem Rev; 2005 Mar; 105(3):775-91. PubMed ID: 15755076
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies for the design of RNA-binding small molecules.
    Aboul-ela F
    Future Med Chem; 2010 Jan; 2(1):93-119. PubMed ID: 21426048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular recognition between the ribosomal decoding site and natural or non-natural aminoglycosides.
    Westhof E
    Nucleic Acids Symp Ser (Oxf); 2005; (49):59-60. PubMed ID: 17150632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular contacts between antibiotics and the 30S ribosomal particle.
    Wirmer J; Westhof E
    Methods Enzymol; 2006; 415():180-202. PubMed ID: 17116475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aminoglycoside microarray platform for directly monitoring and studying antibiotic resistance.
    Disney MD; Barrett OJ
    Biochemistry; 2007 Oct; 46(40):11223-30. PubMed ID: 17867707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance.
    Bastida A; Hidalgo A; Chiara JL; Torrado M; Corzana F; Pérez-Cañadillas JM; Groves P; Garcia-Junceda E; Gonzalez C; Jimenez-Barbero J; Asensio JL
    J Am Chem Soc; 2006 Jan; 128(1):100-16. PubMed ID: 16390137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convenient synthesis of orthogonally protected 2-deoxystreptamine (2-DOS) as an aminocyclitol scaffold for the development of novel aminoglycoside antibiotic derivatives against bacterial resistance.
    Bauder C
    Org Biomol Chem; 2008 Aug; 6(16):2952-60. PubMed ID: 18688488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic studies of Homo sapiens ribosomal decoding A site complexed with aminoglycosides.
    Kondo J; François B; Urzhumtsev A; Westhof E
    Nucleic Acids Symp Ser (Oxf); 2005; (49):253-4. PubMed ID: 17150729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.
    Pokrovskaya V; Nudelman I; Kandasamy J; Baasov T
    Methods Enzymol; 2010; 478():437-62. PubMed ID: 20816493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.